Drug
ARC-520 clinical trials
Also written ARC-520.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
7 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ARC-520 is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02604212Written as ARC-520
- A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02065336Written as ARC-520
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02738008Written as ARC-520 Injection
- A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02604199Written as ARC-520 Injection
- Safety and Tolerability Study of ARC-520 in Healthy VolunteersCompletedPhase 1Arrowhead PharmaceuticalsNCT01872065Written as ARC-520
- Study of ARC-520 in Patient With Chronic Hepatitis B VirusWithdrawnPhase 2Arrowhead PharmaceuticalsNCT02349126Written as ARC-520 Injection
- Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B VirusTerminatedPhase 2Arrowhead PharmaceuticalsNCT02452528Written as ARC-520
Given in every arm · 2 — ARC-520 is usual care beside what is tested
- A Study of ARC-520 at Varying Infusion Rates in Healthy Adult VolunteersCompletedPhase 1Arrowhead PharmaceuticalsNCT02535416Written as ARC-520
- Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)TerminatedPhase 2Arrowhead PharmaceuticalsNCT02577029Written as ARC-520
Codes
What other systems call ARC-520 · ClinicalTrials.gg INT001621
- MeSH (NLM) C000717093ARC-520One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000717093 | ARC-520 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.